Metabolic markers as prognostic factors for complications of abdominoplasty

Introduction. Performing plastic surgery, in particular, abdominoplasty, is characterized by a high risk of complications, primarily seromas. It is assumed that the cause of poor wound healing results in these patients may be proteolytic disorders. At the same time, it is believed that some biological markers can be considered as factors for predicting the risk of complications.
The aim of the work was to analyze the literature data on the role of biologically active substances as risk factors for the development of complications of abdominoplasty.
Results. A number of studies have demonstrated the different effects of body contouring surgery on glucose metabolism. At the same time, there was a significant improvement in insulin sensitivity after the interventions, but no significant normalization of fasting glucose levels was detected. Information about changes in the lipid profile of patients undergoing plastic surgery is contradictory, and a number of studies have noted a significant normalization of high-density lipoprotein levels. In the light of modern ideas about the role of adipose tissue as a source of pro-inflammatory cytokines (in particular, interleukin-4), it is obvious that liposuction during abdominoplasty can help reduce the severity of inflammatory reactions in the body. Attention is drawn to the possibility of using C-reactive protein as a marker for predicting complications during body contouring. The prospects of evaluating the activity of enzymes of the matrix metalloproteinase family, whose role as pro-inflammatory mediators and modulators of immunity is currently widely recognized, are noted.
Conclusion. It is concluded that it is necessary to further improve the tools for predicting the development of complications during plastic surgery, in particular abdominal and contouring.

1. Radhakrishnan M., Ramamurthy K. Efficacy and Challenges in the Treatment of Diastasis Recti Abdominis-A Scoping Review on the Current Trends and Future Perspectives. Diagnostics (Basel), 2022, vol. 12(9), pр. 2044. https://doi.org/10.3390/diagnostics12092044

2. Henderson J.T., Koenig Z.A., Woodberry K.M. Changes in Glucose Control and Lipid Levels Following Trunk-Based Body Contouring Surgery in Postbariatric and Nonbariatric Patients. Aesthet. Surg. J. Open. Forum, 2022, vol.13 (4), рр. ojac076. https://doi.org/10.1093/asjof/ojac076

3. Araco A., Sorge R., Overton J. et al. Postbariatric patients undergoing body-contouring abdominoplasty: Two techniques to raise the flap and their influence on postoperative complications. Ann. Plast. Surg., 2009, № 62, pp.613–617. https://doi.org/10.1097/SAP.0b013e3181856d85

4. Martin-Del-Campo L.A., Herrera M.F., Pantoja J.P. et al. Absence of an additional metabolic effect of body contour surgery in patients with massive weight loss after laparoscopic Roux-En-Y gastric bypass. Ann. Plast. Surg., 2017, № 79(6), pp. 533–535. https://doi.org/10.1097/SAP.0000000000001168

5. Vinci V., Valaperta S., Klinger M. et al. Metabolic implications of surgical fat removal: increase of adiponectin plasma levels after reduction mammaplasty and abdominoplasty. Ann. Plast. Surg., 2016, № 76(6), pp. 700–704. https://doi.org/10.1097/SAP.0000000000000240

6. Seretis K., Goulis D.G., Koliakos G., Demiri E. The effects of abdominal lipectomy in metabolic syndrome components and insulin sensitivity in females: a systematic review and meta-analysis. Metabolism, 2015, № 64(12), pp. 1640–1649. https://doi.org/10.1016/j.metabol.2015.09.015

7. Huth S., Huth L., Marquardt Y. et al. MMP-3 plays a major role in calcium pantothenate-promoted wound healing after fractional ablative laser treatment. Lasers Med Sci., 2022, № 37(2), pp. 887–894. https://doi.org/10.1007/s10103-021-03328-8

8. Yadav J.P. Based on Clinical Research Matrix Metalloprotease (MMP) Inhibitors to Promote Diabetic Wound Healing. Horm. Metab. Res., 2023, № 55(11), pp. 752–757. https://doi.org/10.1055/a-2171-5879

9. Giugliano G., Nicoletti G., Grella E. et al. Effect of liposuction on insulin resistance and vascular inflammatory markers in obese women. Br. J. Plast. Surg., 2004, № 57(3), pp. 190–194. https://doi.org/10.1016/j.bjps.2003.12.010

10. Murillo A.L., Kaiser K.A., Smith D.L. et al. A systematic scoping review of surgically manipulated adipose tissue and the regulation of energetics and body fat in animals. Obesity (Silver Spring), 2019, № 27(9), pp. 1404–1417. https://doi.org/10.1002/oby.22511

11. Cintra W., Modolin M., Faintuch J. et al. C-reactive protein decrease after postbariatric abdominoplasty. Inflammation, 2012, № 35(1), pp. 316–320. https://doi.org/10.1007/s10753-011-9321-9

12. Modolin M.L.A., Cintra W., Rocha R.I. et al. Analysis of inflammatory and metabolic biomarkers in patients submitted to abdominoplasty after bariatric surgery. Acta Cir. Bras., 2019, № 34(5), рр. e201900506. https://doi.org/10.1590/s0102-865020190050000006

13. Rizzo M.R., Paolisso G., Grella R. et al. Is dermolipectomy effective in improving insulin action and lowering inflammatory markers in obese women? Clin. Endocrinol. (Oxf), 2005. № 63(3), pp. 253–258. https://doi.org/10.1111/j.1365-2265.2005.02337.x

14. Marfella R., Grella R., Rizzo M.R. et al. Role of subcutaneous abdominal fat on cardiac function and proinflammatory cytokines in premenopausal obese women. Ann. Plast. Surg., 2009, № 63(5), pp. 490–495. https://doi.org/10.1097/SAP.0b013e3181955cdb

15. Ramos-Gallardo G., Pérez Verdin A., Fuentes M. et al. Effect of abdominoplasty in the lipid profile of patients with dyslipidemia. Plast. Surg. Int., 2013, рр. e861348. https://doi.org/10.1155/2013/861348

16. Leibou L., Perlok T., Haiat Factor R. et al. Does abdominoplasty intensify the metabolic effect of bariatric surgery? Isr. Med. Assoc. J., 2020, № 22(6), pp. 374–377.

17. Robles-Cervantes J.A., Espaillat-Pavonessa M., CárdenasCamarena L. et al. Dehydroepiandrosterone behavior and lipid profile in nonobese women undergoing abdominoplasty. Obes. Surg., 2007, № 17(3), pp. 361–364. https://doi.org/10.1007/s11695-007-9065-7

18. Swanson E. Prospective clinical study reveals significant reduction in triglyceride level and white blood cell count after liposuction and abdominoplasty and no change in cholesterol levels. Plast. Reconstr. Surg., 2011, № 128(3), pp. 182–197. https://doi.org/10.1097/PRS.0b013e31822213c6

19. Esposito K., Giovanni G., Scuderi N., Giugliano D. Role of adipokines in the obesity-inflammation relationship: the effect of fat removal. Plast. Reconstr. Surg., 2006, № 118(4), pp. 1048–1057. https://doi.org/10.1097/01 prs.0000232281.49432.ce

20. Vozarova B., Weyer C., Hanson K. et al. Circulating Interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes. Res., 2001, № 9(7), pp. 414–417. https://doi.org/10.1038/oby.2001.54

21. Wensveen F.M., Valentic S., Sestan M. et al. The “Big Bang” in obese fat: events initiating obesity-induced adipose tissue inflammation. Eur. J. Immunol., 2015, № 45(9), рр. 2446–2456. https://doi.org/10.1002/eji.201545502

22. Gomez F.I., Ortega M.G., Alonso A.A. et al. Obesity, endothelial function and inflammation: the effects of weight loss after bariatric surgery. Nutr. Hosp., 2016, № 33(6), рр. 1340–1346. https://doi.org/10.20960/nh.793

23. Chiappetta S., Schaack H.M., Wolnerhannsen B. et al. The impact of obesity and metabolic surgery on chronic inflammation. Obes. Surg., 2018, № 28 (10), pp. 3028–3040. https://doi.org/10.1007/s11695-018-3320-y

24. Freitas W.R., Oliveira L.V.F., Perez E.A. et al. Systemic inflammation in severe obese patients undergoing surgery for obesity and weight-related diseases. Obes. Surg., 2018, № 28(7), рр. 1931–1942. https://doi.org/10.1007/s11695- 017-3104-9

25. Sippel C.A., Bastin R.M.A., Giovanella J. et al. Inflammatory processes of obesity. Rev. Aten. Saúde., 2014, № 12(42), pp. 48–56. https://doi.org/10.13037/rbcs. vol12n42.2310

26. Tsao C.H., Shiau M.Y., Chuang P.H. et al. Interleukin-4 regulates lipid metabolism by inhibiting adipogenesis and promoting lipolysis. J. Lipid Res., 2014, № 5(3), pp. 385–397. https://doi.org/10.1194/jlr.M041392

27. Wigner N.A., Kulkarni N., Yakavonis M. et al. Urine matrix metalloproteinases (MMPs) as biomarkers for the progression of fracture healing. Injury, 2012, № 43, pp. 274–278. https://doi.org/10.1016/j.injury.2011.05.038

28. Utz E.R., Elster E.A., Tadaki D.K. et al. Metalloproteinase expression is associated with traumatic wound failure. J. Surg. Res., 2010, № 159, pp. 633–639. https://doi.org/10.1016/j.jss.2009.08.021

29. Andrade V.L., Petruceli E., Belo V.A. et al. Evaluation of plasmatic MMP-8, MMP-9, TIMP-1 and MPO levels in obese and lean women. Clin. Biochem., 2012, № 45(6), pp. 412–415. https://doi.org/10.1016/j.clinbiochem.2012.01.008

30. Gill S.E., Parks W.C. Metalloproteinases and their inhibitors: Regulators of wound healing. Int. J. Biochem. Cell Biol., 2008, № 40, pp. 1334–1347. https://doi.org/10.1016/j.biocel.2007.10.024